跳至主要内容
临床试验/NCT00327275
NCT00327275已完成不适用

The Strength Training and Remicade Study

University of Arizona2 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2004年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
35
试验地点
2
主要终点
Strength

研究概览

简要总结

To assess the effects of a 16-week individualized, intensive strength training program in patients with rheumatoid arthritis. Primary and secondary outcomes include: strength and body composition, function, disease activity, pain, quality of life.

We hypothesized that improvements would be seen in all of the above outcomes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Males and females with RA
  • Over 18 years of age
  • ACR Functional Class I and II
  • Taking Remicade >4 months

排除标准

  • Presence of comorbid conditions contraindicated to exercise, including, but not limited to:
  • heart disease
  • severe osteoporosis: (if >50 years): T score < -3.0 for hip or spine excluded; T score <-2.5 for hip or spine w/o current treatment)
  • (all potential subjects) previous non-traumatic fractures
  • uncontrolled BP
  • Regular use of assistive walking device which would interfere with ability to lift weights
  • Currently or within the last 3 months participating in aerobic exercise > 150 minutes a week
  • Currently or within the last 3 months participating in any regular strength training activities
  • Presence of neurological impairment that directly limits ability to perform exercise
  • Participation in concurrent exercise study
  • Any reason for which the investigator deems it would not be in the patient's best interest to continue in the study
  • Plans to move away from site within next 1 year

结局指标

主要结局

Strength

Body Composition

Function

Pain

次要结局

  • Disease Activity
  • Fatigue
  • Quality of Life

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验